News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) to Build $200 Million Manufacturing Plant in China Medical City



10/10/2011 11:50:29 AM

October 10, 2011 -- AstraZeneca will spend $200 million to build a major new manufacturing facility in Taizhou’s China Medical City. The plant, which will produce both IV and solid oral medications for the China market, is the largest investment AstraZeneca has ever made in a single manufacturing site. China is becoming increasing important to AstraZeneca. In the first half of 2011, the company’s revenues in the PRC grew 22% to $624 million. More details....

Stock Symbol: (NYSE: AZN)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES